About Harrisvaccines
Harrisvaccines is a company based in Ames (United States) founded in 2005 was acquired by Merck Animal Health in November 2015.. Harrisvaccines has raised $5 million across 3 funding rounds from investors including Merck Animal Health, NIFA and United States Department of Agriculture. Harrisvaccines offers products and services including Vaccines, Medicines, and DNA TraceBack. Harrisvaccines operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Ames, United States
-
Sectors
HealthcareAgriculture
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Merck & Co., Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Merck Animal Health
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Merck Animal Health
(Nov 12, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Harrisvaccines
Harrisvaccines offers a comprehensive portfolio of products and services, including Vaccines, Medicines, and DNA TraceBack. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Vaccines for preventing diseases in companion and livestock animals
Medicines to treat animal health conditions and improve welfare
Technology for tracking and monitoring animal genetics and health
Funding Insights of Harrisvaccines
Harrisvaccines has successfully raised a total of $5M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(01 Sep 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2013 | Amount | Grant - Harrisvaccines | Valuation |
investors |
|
| Oct, 2011 | Amount | Series A - Harrisvaccines | Valuation |
investors |
|
| Sep, 2011 | Amount | Grant - Harrisvaccines | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Harrisvaccines
Harrisvaccines has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Merck Animal Health, NIFA and United States Department of Agriculture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Vaccine technology is developed and supplied for livestock animals.
|
Founded Year | Domain | Location | |
|
Leadership is provided on agriculture, food, and rural development matters.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Harrisvaccines
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Harrisvaccines
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Harrisvaccines Comparisons
Competitors of Harrisvaccines
Harrisvaccines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Harrisvaccines
When was Harrisvaccines founded?
Harrisvaccines was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Where is Harrisvaccines located?
Harrisvaccines is headquartered in Ames, United States. It is registered at Ames, Iowa, United States.
Is Harrisvaccines a funded company?
Harrisvaccines is a funded company, having raised a total of $5M across 3 funding rounds to date. The company's 1st funding round was a Grant of $460K, raised on Sep 01, 2011.
What does Harrisvaccines do?
Harrisvaccines uses RNA Particle (RP) technology to develop herd-specific vaccines. The technology developed by the company to develop the vaccine does not need the virus, instead, it needs only the data to determine the subtype or strain of a specific virus. The gene sequence of the virus is considered for developing the vaccine. Using its technology the company developed a vaccine called iPED in 2013 to fight Porcine Epidemic Diarrhea virus in an epidemic across Canada and North America. The company had also developed a Swine Influenza Vaccine, which was licensed for use as an aid in the prevention of disease caused by Swine Influenza, H3N2.
Who are the top competitors of Harrisvaccines?
Harrisvaccines's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Harrisvaccines offer?
Harrisvaccines offers Vaccines, Medicines, and DNA TraceBack.
Who are Harrisvaccines's investors?
Harrisvaccines has 3 investors. Key investors include Merck Animal Health, NIFA, and United States Department of Agriculture.